| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 38,485 | 35,075 | ||
| Short-term investments | 190,202 | 214,645 | ||
| Accounts receivable, net | 11,539 | 11,395 | ||
| Inventories, net | 20,373 | 17,323 | ||
| Prepaid expenses and other current assets | 9,427 | 7,637 | ||
| Total current assets | 270,026 | 286,075 | ||
| Total cost | 13,673 | - | ||
| Less accumulated depreciation and amortization | 6,288 | - | ||
| Property and equipment, net | 7,385 | 6,465 | ||
| Operating lease right-of-use asset | 7,024 | 6,038 | ||
| Restricted cash | 100 | 100 | ||
| Long-term investments | 45,328 | 31,149 | ||
| Other long-term assets | 183 | 144 | ||
| Total assets | 330,046 | 329,971 | ||
| Accounts payable | 4,461 | 3,424 | ||
| Accrued expenses and other current liabilities | 17,605 | 13,405 | ||
| Operating lease liabilities | 1,980 | 1,519 | ||
| Deferred revenue | 1,342 | 1,141 | ||
| Total current liabilities | 25,388 | 19,489 | ||
| Operating lease liabilities, net of current portion | 5,707 | 5,168 | ||
| Deferred revenue, net of current portion | 2,986 | 2,670 | ||
| Other long-term liabilities | 1,205 | 1,011 | ||
| Total liabilities | 35,286 | 28,338 | ||
| Common stock-Common Class A | 0 | 0 | ||
| Common stock-Common Class B | 0 | 0 | ||
| Common stock-Common Class C | 0 | 0 | ||
| Preferred stock | 0 | 0 | ||
| Common stock | 4 | 4 | ||
| Additional paid-in capital | 650,873 | 643,742 | ||
| Accumulated other comprehensive income | 354 | 149 | ||
| Accumulated deficit | -356,471 | -342,262 | ||
| Total stockholders' equity (deficit) | 294,760 | 301,633 | ||
| Total liabilities, convertible preferred stock and stockholders' equity (deficit) | 330,046 | 329,971 | ||
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)